FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

766842008: Antigen of Human papillomavirus type 16 L1 capsid protein (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3662848019 Human papillomavirus type 16 L1 capsid protein Ag en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT core
3662871017 Human papillomavirus type 16 L1 capsid protein antigen en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT core
3745881015 Antigen of Human papillomavirus type 16 L1 capsid protein (substance) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
3745882010 Antigen of Human papillomavirus type 16 L1 capsid protein en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
3745884011 HPV (Human papillomavirus) type 16 L1 capsid protein antigen en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT core


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Human papillomavirus type 16 L1 capsid protein antigen est un(e) (attribut) Antigen of Human papillomavirus L1 capsid protein (substance) true Inferred relationship Some
Human papillomavirus type 16 L1 capsid protein antigen est un(e) (attribut) antigène du papillomavirus humain de type 16 true Inferred relationship Some
Human papillomavirus type 16 L1 capsid protein antigen est un(e) (attribut) Protein antigen false Inferred relationship Some
Human papillomavirus type 16 L1 capsid protein antigen est un(e) (attribut) antigène viral false Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
CERVARIX 40 micrograms per 0.5 milliliter suspension for injection GlaxoSmithKline Inc. (real clinical drug) a pour principe actif (attribut) True Human papillomavirus type 16 L1 capsid protein antigen Inferred relationship Some 1
GARDASIL 9 270 micrograms per 0.5 milliliter suspension for injection Merck Canada Inc. (real clinical drug) a pour principe actif (attribut) True Human papillomavirus type 16 L1 capsid protein antigen Inferred relationship Some 8
GARDASIL 120 micrograms per 0.5 milliliter suspension for injection Merck Canada Inc. (real clinical drug) a pour principe actif (attribut) True Human papillomavirus type 16 L1 capsid protein antigen Inferred relationship Some 3

This concept is not in any reference sets

Back to Start